- Home
- RYTM vs IFS Comparison
RYTM vs IFS Comparison
Compare RYTM & IFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- IFS
- Stock Information
- Founded
- RYTM 2008
- IFS 1897
- Country
- RYTM United States
- IFS Peru
- Employees
- RYTM N/A
- IFS N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- IFS Commercial Banks
- Sector
- RYTM Health Care
- IFS Finance
- Exchange
- RYTM Nasdaq
- IFS Nasdaq
- Market Cap
- RYTM 3.2B
- IFS 3.3B
- IPO Year
- RYTM 2017
- IFS 2019
- Fundamental
- Price
- RYTM $57.24
- IFS $30.70
- Analyst Decision
- RYTM Strong Buy
- IFS Buy
- Analyst Count
- RYTM 12
- IFS 1
- Target Price
- RYTM $73.58
- IFS $30.00
- AVG Volume (30 Days)
- RYTM 795.0K
- IFS 211.9K
- Earning Date
- RYTM 05-06-2025
- IFS 05-12-2025
- Dividend Yield
- RYTM N/A
- IFS 3.22%
- EPS Growth
- RYTM N/A
- IFS 21.96
- EPS
- RYTM N/A
- IFS 3.02
- Revenue
- RYTM $130,126,000.00
- IFS $1,189,396,011.00
- Revenue This Year
- RYTM $45.46
- IFS N/A
- Revenue Next Year
- RYTM $63.04
- IFS $8.47
- P/E Ratio
- RYTM N/A
- IFS $10.31
- Revenue Growth
- RYTM 68.06
- IFS 9.69
- 52 Week Low
- RYTM $35.17
- IFS $20.56
- 52 Week High
- RYTM $68.58
- IFS $34.60
- Technical
- Relative Strength Index (RSI)
- RYTM 48.62
- IFS 39.60
- Support Level
- RYTM $45.91
- IFS $29.09
- Resistance Level
- RYTM $63.11
- IFS $31.47
- Average True Range (ATR)
- RYTM 3.46
- IFS 0.93
- MACD
- RYTM 0.29
- IFS -0.42
- Stochastic Oscillator
- RYTM 36.33
- IFS 29.32
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About IFS Intercorp Financial Services Inc.
Intercorp Financial Services Inc is a provider of financial services through banking, insurance, and wealth management businesses, as well as the recent integration of Izipay enhancing its payments ecosystem. The company has four operating segments; the Banking segment includes Mainly loans, credit facilities, deposits, and current accounts, the Insurance segment provides life annuity products with single-premium payment and conventional life insurance products and other retail insurance products, the Wealth Management segment provides brokerage and investment management services, and Payments segment provides administration services, operation and processing of credit and debit cards. Its geographical segments include Peru and Panama.